Craig Bijou

Stock Analyst at B of A Securities

(3.85)
# 451
Out of 4,829 analysts
62
Total ratings
64.71%
Success rate
61.33%
Average return

Stocks Rated by Craig Bijou

PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104$84
Current: $53.11
Upside: +58.16%
RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60$36
Current: $13.06
Upside: +175.65%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235$140
Current: $125.11
Upside: +11.90%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18$17
Current: $11.27
Upside: +50.84%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80$97
Current: $55.82
Upside: +73.77%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26$18
Current: $12.25
Upside: +46.94%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135$145
Current: $118.44
Upside: +22.42%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92$103
Current: $95.83
Upside: +7.48%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $68.19
Upside: +24.65%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94$86
Current: $69.87
Upside: +23.09%
Initiates: Buy
Price Target: $95
Current: $82.26
Upside: +15.49%
Maintains: Buy
Price Target: $43$36
Current: $18.49
Upside: +94.70%
Reiterates: Overweight
Price Target: $23$45
Current: $5.98
Upside: +653.14%
Maintains: Overweight
Price Target: $1$8
Current: $0.43
Upside: +1,773.98%
Maintains: Neutral
Price Target: $60$30
Current: $4.65
Upside: +545.16%
Reiterates: Overweight
Price Target: $17$13
Current: $8.71
Upside: +49.25%
Maintains: Neutral
Price Target: $48$42
Current: $12.11
Upside: +246.82%
Reiterates: Overweight
Price Target: $207$230
Current: $536.51
Upside: -57.13%
Maintains: Neutral
Price Target: $190$230
Current: $380.92
Upside: -39.62%